| 鲍峻峻,梅俏,孟翔凌,等.胰管支架预防内镜下逆行胰胆管造影术后胰腺炎的临床分析[J].安徽医药,2016,20(9):1712-1714. |
| 胰管支架预防内镜下逆行胰胆管造影术后胰腺炎的临床分析 |
| Pancreatic duct stent in prevention of post-ERCP pancreatitis |
| 投稿时间：2016-04-09 |
| DOI： |
| 中文关键词: 胰胆管造影术,内窥镜逆行/方法 支架 胰腺炎 |
| 英文关键词: |
| 基金项目:安徽省科技厅重点项目(12070403071) |
|
| 摘要点击次数: 3029 |
| 全文下载次数: 70 |
| 中文摘要: |
| 目的 回顾性研究内镜下胰管支架置入预防内镜下逆行胰胆管造影术后胰腺炎(PEP)疗效。方法 按统一标准入组相关患者,选择接受内镜下逆行胰胆管造影(ERCP)诊治并置入胰管支架的102例患者作为观察组,随机选择同期接受ERCP治疗但未置入胰管支架的患者100例作为对照组,比较两组患者PEP及高淀粉酶血症的发生率。结果(1)观察组与对照组总体术后胰腺炎发生率差异无统计学意义(P=0.113)；两组总体高淀粉酶血症发生率相比差异无统计学意义(P=0.491)。(2)两组高危人群术后胰腺炎发生率相比差异有统计学意义(P=0.037)；高危人群高淀粉酶血症发生率相比差异无统计学意义(P=0.757)。结论 胰管支架置入可降低高危人群ERCP术后胰腺炎的发生率。 |
| 英文摘要: |
| Objective To retrospectively study the effect of the placement of endoscopic pancreatic duct stent in prevention of post-ERCP pancreatitis(PEP).Methods According to the unified standards,102 patients with pancreatic duct stent and 100 patients without pancreatic duct stent during ERCP treatment were assigned into treatment group and control group,and the incidences of PEP and hyperamylasemia were compared between the two groups.Results There was no significant difference in the incidence of PEP(P=0.113) and hyperamylasemia(P=0.491) between the two groups.There was significant difference in the incidence of PEP between the high risk population of two groups(P=0.037),but there was no significant difference in the incidence of hyperamylasemia between the high risk population of two groups(P=0.757).Conclusions Pancreatic duct stent can reduce the incidence of PEP in high risk population. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
|
|
|
